L295-0555 Screening compound: 3,5,6-trimethyl-N-(5-methyl-1,2-oxazol-3-yl)-2-(piperidine-1-carbonyl)-1-benzofuran-7-sulfonamide

L295-0555 Screening compound: 3,5,6-trimethyl-N-(5-methyl-1,2-oxazol-3-yl)-2-(piperidine-1-carbonyl)-1-benzofuran-7-sulfonamide
L295-0555 Screening compound: 3,5,6-trimethyl-N-(5-methyl-1,2-oxazol-3-yl)-2-(piperidine-1-carbonyl)-1-benzofuran-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L295-0555
3,5,6-trimethyl-N-(5-methyl-1,2-oxazol-3-yl)-2-(piperidine-1-carbonyl)-1-benzofuran-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L295-0555

Molecular Formula

C21H25N3O5S (C21 H25 N3 O5 S)

Compound Name

3,5,6-trimethyl-N-(5-methyl-1,2-oxazol-3-yl)-2-(piperidine-1-carbonyl)-1-benzofuran-7-sulfonamide

IUPAC name

356-trimethyl-N-(5-methyl-12-oxazol-3-yl)-2-(piperidine-1-carbonyl)-1-benzofuran-7-sulfonamide

SMILES

Cc1cc(NS(c2c(C)c(C)cc3c2oc(C(N2CCCCC2)=O)c3C)(=O)=O)no1

InChI

InChI=1S/C21H25N3O5S/c1-12-10-16-15(4)18(21(25)24-8-6-5-7-9-24)28-19(16)20(14(12)3)30(26,27)23-17-11-13(2)29-22-17/h10-11H,5-9H2,1-4H3,(H,22,23)

InChI Key

NKEYKJRCPLXEMK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27242085

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.51

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.979

Distribution Coefficient, logD

-0.259

Water Solubility, LogSw

-3.86

Polar Surface Area

88.091

Acid Dissociation Constant (pKa)

3.16

Base Dissociation Constant (pKb)

0.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

42.90

L295-0555 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with L295-0555 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L295-0555?
Check Price and Availability of L295-0555, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L295-0555 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L295-0555
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L295-0555
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L295-0555 available by request